AbcamBiochemicals

Lovastatin (Mevinolin) (ab120614)

Overview

  • Product nameLovastatin (Mevinolin)
  • Description
    Potent HMG CoA reductase inhibitor
  • Alternative names
    • Mevinolin
  • Biological descriptionPotent, competitive HMG CoA reductase inhibitor (Ki = 0.6 nM). Blood brain barrier permeable. Inhibits in vivo and in vitro cholesterol biosynthesis. Also reduces α-synuclein levels in vitro and in vivo.
  • Purity> 98%

Properties

    Applications

    Our Abpromise guarantee covers the use of ab120614 in the following tested applications.

    The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

    Application Abreviews Notes
    Functional Studies Use at an assay dependent concentration.

    Lovastatin (Mevinolin) images

    • ab87359 staining cyclin A in DU145 cells treated with lovastatin (ab120614), by ICC/IF. Decrease in cyclin A expression correlates with increased concentration of lovastatin, as described in literature.
      The cells were incubated at 37°C for 24h in media containing different concentrations of ab120614 (lovastatin) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab87359 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

    References for Lovastatin (Mevinolin) (ab120614)

    This product has been referenced in:
    • Koob AO  et al. Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Exp Neurol 221:267-74 (2010). Read more (PubMed: 19944097) »
    • Chen GZ  et al. Purification and characterization of 3-hydroxymethylglutaryl-coenzyme A reductase of Schistosoma mansoni: regulation of parasite enzyme activity differs from mammalian host. Exp Parasitol 73:82-92 (1991). Read more (PubMed: 1905241) »
    • Singer II  et al. Lovastatin, an inhibitor of cholesterol synthesis, induces hydroxymethylglutaryl-coenzyme A reductase directly on membranes of expanded smooth endoplasmic reticulum in rat hepatocytes. Proc Natl Acad Sci U S A 85:5264-8 (1988). Read more (PubMed: 3293052) »

    See 0 Publications for this product

    Product Wall

    There are currently no Questions for ab120614.
    Please use the link above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"